Clinical Response in Rheumatoid Arthritis Patients with Anti-Infliximab Antibodies

被引：0
|
作者：
Opris, Daniela [1 ]
Mazilu, Diana [1 ]
Ionescu, Ruxandra [1 ]
机构：
[1] Carol Davila Univ MEd, Sfanta Maria Hosp, Dept Rheumatol, Bucharest, Romania
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2014年 / 32卷 / 04期
关键词：
Rheumatoid arthritis; infliximab; immunogenicity; methotrexate;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P-132
引用
收藏
页码：S40 / S41
页数：2
相关论文
共 50 条
  • [1] Anti-infliximab antibodies in patients with rheumatoid arthritis who require higher doses of infliximab to achieve or maintain a clinical response
    Haraoui, B
    Cameron, L
    Ouellet, M
    White, B
    [J]. JOURNAL OF RHEUMATOLOGY, 2006, 33 (01) : 31 - 36
  • [2] A single course of rituximab does not abrogate anti-infliximab antibodies in patients with rheumatoid arthritis
    van den Bemt, B. J. F.
    Vos, K.
    den Broeder, A. A.
    Blom, M.
    Thurlings, R. M.
    Bartelds, G. M.
    Stapel, S. O.
    Barrera, P.
    Tak, P. P.
    Nurmohamed, M. T.
    Wolbink, G-J
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (08) : 1368 - 1369
  • [3] Influence of anti-infliximab antibodies and residual infliximab concentrations on the occurrence of acquired drug resistance to infliximab in rheumatoid arthritis patients
    Finckh, Axel
    Dudler, Jean
    Wermelinger, Felix
    Ciurea, Adrian
    Kyburz, Diego
    Gabay, Cem
    Bas, Sylvette
    [J]. JOINT BONE SPINE, 2010, 77 (04) : 313 - 318
  • [4] ESTABLISHING CUT-OFF OF INFLIXIMAB LEVELS AND ANTI-INFLIXIMAB ANTIBODIES BY COMMERCIAL ELISA IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Hernandez, Diana
    Valor, Lara
    de la Torre, Inmaculada
    Martinez, Lina
    Carlos Nieto, Juan
    del Rio, Tamara
    Naredo, Esperanza
    Gonzalez, Carlos
    Lopez-Longo, Javier
    Montoro, Maria
    Monteagudo, Indalecio
    Carreno, Luis
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : A11 - A11
  • [5] ANTI-INFLIXIMAB ANTIBODIES IMPAIR CLINICAL RESPONSE TO INFLIXIMAB IN JIA ASSOCIATED UVEITIS
    Metha, R.
    Tay-Kearney, M.
    Manners, P.
    Murray, K.
    [J]. INTERNAL MEDICINE JOURNAL, 2012, 42 : 32 - 33
  • [6] Anti-infliximab antibodies in patients with an infusion-related allergic response to infliximab
    Wolbink, GJ
    De Groot, E
    Lems, WF
    Nurmohamed, MT
    Tak, PP
    Dijkmans, BAC
    Voskuyl, AE
    Aarden, L
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 179 - 179
  • [7] Concentrations of infliximab and anti-drug antibodies in relation to clinical response in patients with rheumatoid arthritis
    Siljehult, F.
    Arlestig, L.
    Eriksson, C.
    Rantapaa-Dahlqvist, S.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2018, 47 (05) : 345 - 350
  • [8] The Monitoring of Infliximab Levels at Early Stages Can Predict the Development of Anti-Infliximab Antibodies in a Cohort of Rheumatoid Arthritis Patients Treated with Infliximab
    Plasencia-Rodriguez, Chamaida
    Pascual-Salcedo, Dora
    Gema Bonilla, Maria
    Villalba, Alejandro
    Peiteado, Diana
    Nuno, Laura
    Aguado, Pilar
    Jurado, Teresa
    Martin-Mola, Emilio
    Balsa, Alejandro
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1098 - S1098
  • [9] Anti-infliximab antibodies in patients with an infusion related allergic response to infliximab.
    Wolbink, G
    de Groot, E
    Lems, W
    Dijkmans, B
    Nurmohamed, M
    Tak, PP
    Voskuyl, A
    Aarden, L
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S326 - S326
  • [10] Detection of anti-infliximab antibodies is of limited value to predict acquired drug resistance to infliximab in rheumatoid arthritis
    Finckh, Axel
    Dudler, Jean
    Wennelinger, Felix
    Ciurca, Adrian
    Gabay, Cem
    Bas, Sylvette
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S777 - S777
12345